A pharmacogenomic genome-wide association study (GWAS) for new onset diabetes (NOD) in the international verapamil sr-trandolapril study (INVEST)

Category Systematic review
JournalClinical Pharmacology and Therapeutics
Year 2014
This article has no abstract
Epistemonikos ID: 5fa2d6f2d61152733a98e7c60b9c1110ddc4a1d8
First added on: Feb 06, 2025